{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T01:48:51Z","timestamp":1779328131911,"version":"3.51.4"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.cca.2019.10.035","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T12:45:27Z","timestamp":1573735527000},"page":"179-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Bone biomarkers in de novo renal transplant recipients"],"prefix":"10.1016","volume":"501","author":[{"given":"Pieter","family":"Evenepoel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne","family":"Cavalier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick C.","family":"D'Haese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2019.10.035_b0005","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2019.10.035_b0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.semnephrol.2012.12.019","article-title":"Recovery versus persistence of disordered mineral metabolism in kidney transplant recipients","volume":"33","author":"Evenepoel","year":"2013","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.cca.2019.10.035_b0015","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/j.ajkd.2012.07.022","article-title":"CKD-mineral and bone disorder management in kidney transplant recipients","volume":"61","author":"Alshayeb","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cca.2019.10.035_b0020","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s40620-017-0424-8","article-title":"Update on the role of bone biopsy in the management of patients with CKD-MBD","volume":"30","author":"Evenepoel","year":"2017","journal-title":"J. Nephrol."},{"key":"10.1016\/j.cca.2019.10.035_b0025","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.semnephrol.2014.09.004","article-title":"When, how, and why a bone biopsy should be performed in patients with chronic kidney disease","volume":"34","author":"Torres","year":"2014","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.cca.2019.10.035_b0030","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2215\/CJN.09850916","article-title":"Spine trabecular bone score as an indicator of bone microarchitecture at the peripheral skeleton in kidney transplant recipients","volume":"12","author":"Luckman","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.10.035_b0035","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s11914-017-0362-3","article-title":"Biomarkers predicting bone turnover in the setting of CKD","volume":"15","author":"Evenepoel","year":"2017","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.cca.2019.10.035_b0040","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S2213-8587(17)30184-5","article-title":"Use of bone turnover markers in postmenopausal osteoporosis","volume":"5","author":"Eastell","year":"2017","journal-title":"Lancet Diabetes Endocrinol.."},{"key":"10.1016\/j.cca.2019.10.035_b0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00198-015-3374-9","article-title":"Bone remodeling markers: so easy to measure, so difficult to interpret","volume":"27","author":"Seeman","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.cca.2019.10.035_b0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/jbmr.5650110107","article-title":"Heterogeneity of the skeleton: comparison of the trabecular microarchitecture of the spine, the iliac crest, the femur, and the calcaneus","volume":"11","author":"Amling","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cca.2019.10.035_b0055","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrrheum.2012.86","article-title":"Bone turnover markers: use in osteoporosis","volume":"8","author":"Naylor","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cca.2019.10.035_b0060","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1053\/j.ajkd.2012.12.013","article-title":"Variability of new bone mineral metabolism markers in patients treated with maintenance hemodialysis: implications for clinical decision making","volume":"61","author":"Cavalier","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cca.2019.10.035_b0065","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ki.2012.77","article-title":"Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patients","volume":"82","author":"Sardiwal","year":"2012","journal-title":"Kidney Int.."},{"key":"10.1016\/j.cca.2019.10.035_b0070","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1210\/jc.2015-2957","article-title":"Are biochemical markers of bone turnover representative of bone histomorphometry in 370 postmenopausal women?","volume":"100","author":"Chavassieux","year":"2015","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.cca.2019.10.035_b0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2009.374","article-title":"Parathyroid hormone measurement in CKD","volume":"77","author":"Souberbielle","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.cca.2019.10.035_b0080","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","article-title":"Parathyroid hormone metabolism and signaling in health and chronic kidney disease","volume":"90","author":"Evenepoel","year":"2016","journal-title":"Kidney Int.."},{"key":"10.1016\/j.cca.2019.10.035_b0085","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0085-2538(15)47156-X","article-title":"A novel mechanism for skeletal resistance in uremia","volume":"58","author":"Slatopolsky","year":"2000","journal-title":"Kidney Int.."},{"key":"10.1016\/j.cca.2019.10.035_b0090","article-title":"Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know","author":"Delanaye","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2019.10.035_b0095","first-page":"11","article-title":"Sclerostin as regulatory molecule in vascular media calcification and the bone-vascular axis","author":"De","year":"2019","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.cca.2019.10.035_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2019.06.007","article-title":"Comparison of serum levels with bone content and gene expression indicate a contradictory effect of kidney transplantation on sclerostin","author":"Araujo","year":"2019","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2019.10.035_b0105","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.semnephrol.2014.02.007","article-title":"Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease?","volume":"34","author":"Evenepoel","year":"2014","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.cca.2019.10.035_b0110","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1046\/j.1523-1755.1999.00589.x","article-title":"Reduced parathyroid functional mass after successful kidney transplantation","volume":"56","author":"Bonarek","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2019.10.035_b0115","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/TP.0000000000000823","article-title":"A prospective cohort study of mineral metabolism after kidney transplantation","volume":"100","author":"Wolf","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.cca.2019.10.035_b0120","first-page":"92","article-title":"Hypercalcemic hyperparathyroidism following renal transplantation: differential diagnosis, management, and implications for cell population control in the parathyroid gland","volume":"8","author":"Parfitt","year":"1982","journal-title":"Miner. Electrolyte Metab"},{"key":"10.1016\/j.cca.2019.10.035_b0125","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/ndt\/gfh128","article-title":"Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study","volume":"19","author":"Evenepoel","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2019.10.035_b0130","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.kint.2016.10.008","article-title":"Bone histomorphometry in de novo renal transplant recipients indicates a further decline in bone resorption 1 year posttransplantation","volume":"91","author":"Evenepoel","year":"2017","journal-title":"Kidney Int.."},{"key":"10.1016\/j.cca.2019.10.035_b0135","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1111\/j.1600-6143.2007.01950.x","article-title":"Low-turnover bone disease in hypercalcemic hyperparathyroidism after kidney transplantation","volume":"7","author":"Borchhardt","year":"2007","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.cca.2019.10.035_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2018.12.024","article-title":"Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients","author":"Evenepoel","year":"2019","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2019.10.035_b0145","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1111\/ajt.12425","article-title":"Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation","volume":"13","author":"Perrin","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.cca.2019.10.035_b0150","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1034\/j.1399-0012.2003.00047.x","article-title":"Hyperparathyroidism and long-term bone loss after renal transplantation","volume":"17","author":"Heaf","year":"2003","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.cca.2019.10.035_b0155","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/jbmr.2358","article-title":"Longitudinal HR-pQCT and image registration detects endocortical bone loss in kidney transplantation patients","volume":"30","author":"Nishiyama","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cca.2019.10.035_b0160","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1681\/ASN.2013080851","article-title":"Kidney transplantation with early corticosteroid withdrawal: paradoxical effects at the central and peripheral skeleton","volume":"25","author":"Iyer","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.10.035_b0165","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1111\/ajt.12911","article-title":"A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism","volume":"14","author":"Evenepoel","year":"2014","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.cca.2019.10.035_b0170","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1681\/ASN.2015060622","article-title":"A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism","volume":"27","author":"Cruzado","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.10.035_b0175","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1681\/ASN.2013111185","article-title":"Paricalcitol for secondary hyperparathyroidism in renal transplantation","volume":"26","author":"Trillini","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.10.035_b0180","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.3074","article-title":"WNT signaling in bone homeostasis and disease: from human mutations to treatments","volume":"19","author":"Baron","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.cca.2019.10.035_b0185","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2215\/CJN.07670712","article-title":"The relation between renal function and serum sclerostin in adult patients with CKD","volume":"8","author":"Pelletier","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.10.035_b0190","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1210\/jc.2013-2786","article-title":"Renal elimination of sclerostin increases with declining kidney function","volume":"99","author":"Cejka","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2019.10.035_b0195","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","article-title":"Repression of osteocyte Wnt\/beta-catenin signaling is an early event in the progression of renal osteodystrophy","volume":"27","author":"Sabbagh","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cca.2019.10.035_b0200","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1097\/TP.0000000000001311","article-title":"Decreased circulating sclerostin levels in renal transplant recipients with persistent hyperparathyroidism","volume":"100","author":"Evenepoel","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.cca.2019.10.035_b0205","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000355781","article-title":"Sclerostin blood levels before and after kidney transplantation","volume":"39","author":"Bonani","year":"2014","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.cca.2019.10.035_b0210","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.transproceed.2014.07.024","article-title":"Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients","volume":"46","author":"Tomei","year":"2014","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.cca.2019.10.035_b0215","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.bone.2013.08.016","article-title":"Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover","volume":"57","author":"Gifre","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.cca.2019.10.035_b0220","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s10067-017-3689-3","article-title":"Glucocorticoid therapy causes contradictory changes of serum Wnt signaling-related molecules in systemic autoimmune diseases","volume":"37","author":"Kawazoe","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cca.2019.10.035_b0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138156","article-title":"Altered osteocyte-specific protein expression in bone after childhood solid organ transplantation","volume":"10","author":"Pereira","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2019.10.035_b0230","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","article-title":"Sclerostin and Dickkopf-1 in renal osteodystrophy","volume":"6","author":"Cejka","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.10.035_b0235","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/ki.2014.372","article-title":"Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease","volume":"87","author":"de Oliveira","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2019.10.035_b0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178637","article-title":"Interactions of sclerostin with FGF23, soluble klotho and vitamin D in renal transplantation","volume":"12","author":"Tartaglione","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2019.10.035_b0245","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/sj.ki.5001788","article-title":"Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?","volume":"70","author":"Bhan","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2019.10.035_b0250","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1600-6143.2007.01753.x","article-title":"Tertiary 'hyperphosphatoninism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients","volume":"7","author":"Evenepoel","year":"2007","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.cca.2019.10.035_b0255","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.3761","article-title":"Glucocorticoids decrease longitudinal bone growth in paediatric kidney transplant recipients by stimulating the FGF23\/FGFR3 signalling pathway","author":"Delucchi","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cca.2019.10.035_b0260","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2215\/CJN.01310308","article-title":"Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation","volume":"3","author":"Evenepoel","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.10.035_b0265","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1681\/ASN.2010080894","article-title":"Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality","volume":"22","author":"Wolf","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.10.035_b0270","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2215\/CJN.00950110","article-title":"Fibroblast growth factor-23 and parathyroid hormone are associated with post-transplant bone mineral density loss","volume":"5","author":"Kanaan","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.10.035_b0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000154","article-title":"Genetic evidence of serum phosphate-independent functions of FGF-23 on bone","volume":"4","author":"Sitara","year":"2008","journal-title":"PLoS Genet."},{"key":"10.1016\/j.cca.2019.10.035_b0280","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bone.2004.03.012","article-title":"Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism","volume":"35","author":"Stilgren","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.cca.2019.10.035_b0285","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1210\/endo.140.9.7131","article-title":"Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.cca.2019.10.035_b0290","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/jcb.21414","article-title":"Dexamethasone promotes osteoclastogenesis by inhibiting osteoprotegerin through multiple levels","volume":"103","author":"Kondo","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.cca.2019.10.035_b0295","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.2215\/CJN.03910411","article-title":"Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease","volume":"6","author":"Scialla","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.10.035_b0300","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00198-005-0047-0","article-title":"Osteoprotegerin and bone mineral density in hemodialysis patients","volume":"17","author":"Nakashima","year":"2006","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.cca.2019.10.035_b0305","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1053\/ajkd.2001.27437","article-title":"Osteoprotegerin levels before and after renal transplantation","volume":"38","author":"Sato","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cca.2019.10.035_b0310","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.transproceed.2006.06.126","article-title":"Renal transplantation decreases osteoprotegerin levels","volume":"38","author":"Bargnoux","year":"2006","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.cca.2019.10.035_b0315","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1681\/ASN.2005121368","article-title":"Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients","volume":"17","author":"Hjelmesaeth","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.10.035_b0320","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2362.2006.01662.x","article-title":"Effect of kidney transplantation on bone","volume":"36","author":"Kodras","year":"2006","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.cca.2019.10.035_b0325","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/oxfordjournals.ndt.a027843","article-title":"Sequential changes of biochemical bone parameters after kidney transplantation","volume":"13","author":"Reinhardt","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2019.10.035_b0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191167","article-title":"Bone metabolism dynamics in the early post-transplant period following kidney and liver transplantation","volume":"13","author":"Schreiber","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2019.10.035_b0335","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cca.2013.07.016","article-title":"Aminoterminal propeptide of type I procollagen (PINP) in chronic kidney disease patients: the assay matters","volume":"425","author":"Cavalier","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2019.10.035_b0340","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/ajt.13692","article-title":"Effect of twice-yearly denosumab on prevention of bone mineral density loss in de novo kidney transplant recipients: a randomized controlled trial","volume":"16","author":"Bonani","year":"2016","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.cca.2019.10.035_b0345","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfy104.FP604","article-title":"Natural history of mineral metabolism, bone turnover and bone mineral density in de novo renal transplant recipients treated with a steroid minimization immunosuppressive protocol","author":"Evenepoel","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2019.10.035_b0350","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2265.2008.03187.x","article-title":"Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction","volume":"69","author":"Yamada","year":"2008","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.cca.2019.10.035_b0355","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.clinbiochem.2014.04.007","article-title":"Inter-method variability in bone alkaline phosphatase measurement: clinical impact on the management of dialysis patients","volume":"47","author":"Cavalier","year":"2014","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2019.10.035_b0360","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1046\/j.1523-1755.2003.00938.x","article-title":"The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling","volume":"63","author":"Rojas","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2019.10.035_b0365","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2215\/CJN.09950818","article-title":"Changes in bone histomorphometry after kidney transplantation","volume":"14","author":"Keronen","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.10.035_b0370","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S8756-3282(01)00662-7","article-title":"Mechanism of circadian variation in bone resorption","volume":"30","author":"Bjarnason","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.cca.2019.10.035_b0375","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13253","article-title":"A 3-year longitudinal study of skeletal effects and growth in children after kidney transplantation","author":"Swolin-Eide","year":"2018","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.cca.2019.10.035_b0380","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00223-008-9127-4","article-title":"Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients","volume":"82","author":"Shidara","year":"2008","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.cca.2019.10.035_b0385","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jpba.2009.03.002","article-title":"Tartrate-resistant acid phosphatase (TRACP 5b): a biomarker of bone resorption rate in support of drug development: modification, validation and application of the BoneTRAP kit assay","volume":"49","author":"Wu","year":"2009","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.cca.2019.10.035_b0390","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1681\/ASN.2018060656","article-title":"A randomized trial of zoledronic acid to prevent bone loss in the first year after kidney transplantation","volume":"30","author":"Marques","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.10.035_b0395","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2215\/CJN.04940419","article-title":"The bone after kidney transplantation","volume":"14","author":"Drueke","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.10.035_b0400","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.kint.2018.12.024","article-title":"Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients","volume":"95","author":"Evenepoel","year":"2019","journal-title":"Kidney Int."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119320996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119320996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:52:01Z","timestamp":1757861521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898119320996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":80,"alternative-id":["S0009898119320996"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2019.10.035","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone biomarkers in de novo renal transplant recipients","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2019.10.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}